The High-Risk Breast Clinic at UofL Health – Brown Cancer Center provides individuals with a high risk for developing breast cancer an opportunity to meet with our multidisciplinary team to discuss ways to their risk.

The multidisciplinary team includes:

  • Dedicated breast oncologist
  • Dedicated gynecologic oncologist
  • Surgeons
  • OB/GYNs
  • Genetics

Being aware of how you can reduce your risk for a cancer diagnosis is very important. This team provides patients with the information and resources necessary to make informed decisions regarding their health. Our goal is to raise awareness of breast cancer and develop a plan for surveillance and risk reduction.

With a personalized treatment plan, patients can make more informed decisions regarding their health including genetic counseling and testing, risk-reducing medications and additional cancer screening/testing.

Patients with a known genetic predisposition (such as BRCA 1 or 2) should be seen by the High-Risk Clinic as early as possible to discuss preventative strategies, as well as surgical and medical management.
Patients who have previous benign findings from breast biopsies may also be seen by the team for future preventative/surveillance strategies.

If you don’t meet any of the above conditions, anyone can schedule an initial visit to discuss your personal risks.

Women may receive a referral to the clinic from their primary care provider or OB/GYN if they have a personal history of: 

  • Breast cancer diagnosis
  • Diagnosis of ovarian cancer
  • Ashkenazi Jewish decent
  • Known mutation in cancer susceptibility gene in the family
  • Dense breast tissue on mammogram
  • A family history of:
    • Two or more relatives on the same side of the family with breast cancer, especially at a young age (less than 50)
    • First or second-degree relatives with breast cancer
    • Ovarian cancer
    • Male breast cancer
    • BRCA 1 and BRCA 2 mutations
    • Other conditions with increased risk of breast cancer such as Cowden syndrome or Li-Fraument syndrome
    • Individuals who had a prior breast biopsy that showed atypical ductal hyperplasia (ADH), lobular carcinoma in situ (LCS), ductal carcinoma in situ (DCS)
    • History of prior chest wall radiation for lymphoma

Patients can typically be seen within one week of referral and the entire family may have genetic testing completed if necessary.

For patients interested in learning more about the High-Risk Clinic or to refer a patient, call 502-562-HOPE (4673).

Calendar icon that indicates scheduling an appointment
Schedule an